Activated ERK Signaling Is One of the Major Hub Signals Related to the Acquisition of Radiotherapy-Resistant MDA-MB-231 Breast Cancer Cells.

作者: Gon Sup Kim , Soon Chan Hong , Bae Kwon Jeong , Won Sup Lee , Jin-Myung Jung

DOI: 10.3390/IJMS22094940

关键词: ChemistryCellCancer stem cellProgrammed cell deathCancer researchMAPK/ERK pathwayApoptosisNecroptosisCD44Cancer

摘要: Breast cancer is one of the major causes deaths due to cancer, especially in women. The crucial barrier for breast treatment resistance radiation therapy, important local regional therapies. We previously established and characterized radio-resistant MDA-MB-231 cells (RT-R-MDA-MB-231 cells) that harbor a high expression stem (CSCs) EMT phenotype. In this study, we performed antibody array analysis identify hub signaling mechanism RT-R-MDA-MB-231 by comparing parental (p-MDA-MB-231) cells. Antibody unveiled MAPK1 protein was most upregulated compared p-MDA-MB-231 pathway enrichment also revealed presence almost all enriched pathways. Thus, used an MEK/ERK inhibitor, PD98059, block role radio-resistance inhibition induced cell death both cells, but each different; underwent apoptosis, showing shrinkage PARP-1 cleavage, while necroptosis, mitochondrial dissipation, nuclear swelling, increase expressions CypA AIF. addition, reversed suppressed increased CSC markers (CD44 OCT3/4) phenotype (β-catenin N-cadherin/E-cadherin). Taken together, study suggests activated ERK signals related

参考文章(67)
Judith S. Sebolt-Leopold, David T. Dudley, Roman Herrera, Keri Van Becelaere, Amy Wiland, Richard C. Gowan, Haile Tecle, Stephen D. Barrett, Alexander Bridges, Sally Przybranowski, W.R. Leopold, Alan R. Saltiel, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Medicine. ,vol. 5, pp. 810- 816 ,(1999) , 10.1038/10533
Wendy J. Cannan, David S. Pederson, Mechanisms and Consequences of Double‐Strand DNA Break Formation in Chromatin Journal of Cellular Physiology. ,vol. 231, pp. 3- 14 ,(2016) , 10.1002/JCP.25048
Pui-Kei Wu, Jong-In Park, MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms Seminars in Oncology. ,vol. 42, pp. 849- 862 ,(2015) , 10.1053/J.SEMINONCOL.2015.09.023
D. T. Dudley, L. Pang, S. J. Decker, A. J. Bridges, A. R. Saltiel, A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 7686- 7689 ,(1995) , 10.1073/PNAS.92.17.7686
Taku Yoshida, Jee Hyun Kim, Kristopher Carver, Ying Su, Stanislawa Weremowicz, Laura Mulvey, Shoji Yamamoto, Cameron Brennan, Shenglin Mei, Henry Long, Jun Yao, Kornelia Polyak, CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer Cancer Research. ,vol. 75, pp. 1516- 1526 ,(2015) , 10.1158/0008-5472.CAN-14-2443
Francesco Marampon, Giovanni Luca Gravina, Agnese Di Rocco, Pierluigi Bonfili, Mario Di Staso, Caterina Fardella, Lorella Polidoro, Carmela Ciccarelli, Claudio Festuccia, Vladimir M. Popov, Richard G. Pestell, Vincenzo Tombolini, Bianca Maria Zani, MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals Molecular Cancer Therapeutics. ,vol. 10, pp. 159- 168 ,(2011) , 10.1158/1535-7163.MCT-10-0631
Fengjuan Lin, Jianmin Luo, Wen Gao, Jiong Wu, Zhimin Shao, Ziliang Wang, Jiao Meng, Zhouluo Ou, Gong Yang, COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness Tumor Biology. ,vol. 34, pp. 2817- 2826 ,(2013) , 10.1007/S13277-013-0840-X
Deepu Oommen, Kevin M. Prise, KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways Biochemical and Biophysical Research Communications. ,vol. 421, pp. 538- 543 ,(2012) , 10.1016/J.BBRC.2012.04.040
Sergej Skvortsov, Paul Debbage, Peter Lukas, Ira Skvortsova, Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways Seminars in Cancer Biology. ,vol. 31, pp. 36- 42 ,(2015) , 10.1016/J.SEMCANCER.2014.06.002
Carrie L Griffiths, Jacqueline L Olin, None, Triple negative breast cancer: a brief review of its characteristics and treatment options. Journal of Pharmacy Practice. ,vol. 25, pp. 319- 323 ,(2012) , 10.1177/0897190012442062